GSK Says It Settled Zantac-Ranitidine Cancer Case Before July California Trial

(June 26, 2023, 12:16 PM EDT) -- LONDON — Drug manufacturer GlaxoSmithKline PLC (GSK) has announced that it has agreed to settle a Zantac-ranitidine bellwether case that was scheduled to go to trial on July 24....

Attached Documents

Related Sections